WaveSense, Inc. Releases Research Products For Melanoma Cells - Expands XRC™ Portfolio

Extending its position in the field of cellular analysis, WaveSense recently announced the availability of the EpiSep™ Melanoma (9.2.27) detection kit. The Melanoma kit utilizes WaveSense’s proprietary Xenographic Retention Chromatography™ (XRC™) technology, and a combination of four antibodies. EpiSep XRC™ is an open platform for rapid and sensitive capture and sorting of live cells, proteins, and genes for interrogation – providing ideal laboratory processes for end-users of the Melanoma kit.

MORE ON THIS TOPIC